Disease Info Card

Lung Diseases, Obstructive

Information about Lung Diseases, Obstructive: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Lung Diseases, Obstructive

Most recent studies have shown that Lung Diseases, Obstructive shares some biological mechanisms with airway-disease, airway-obstruction, asthma, bronchitis, bronchitis-chronic, chronic-obstructive-airway-disease, diabetes-mellitus, dyspnea, fibrosis, heart-diseases, heart-failure, hypertensive-disease, infective-disorder, inflammation, lung-diseases, malignant-neoplasms, pneumonia, pulmonary-emphysema, respiration-disorders, respiratory-failure.

Among the many pathways, these few ones have gauged particular interests from scientists studying Lung Diseases, Obstructive, and have been seen in publications frequently: Aging, Cell Death, Cell Proliferation, Chemotaxis, Coagulation, Cytokine Production, Excretion, Hypersensitivity, Immune Response, Inflammatory Response, Localization, Oxygen Transport, Pathogenesis, Reflex, Regeneration, Secretion, Sensitization, Translation, Transport, Vasoconstriction

Quite a number of genes have been found to play important roles in Lung Diseases, Obstructive, such as ACE, ALB, CFTR, CRP, CS, CSRP1, ELANE, FEV, FUT2, IL13, IL6, MMP9, RANGAP1, SERPINA1, SLC17A5, SQLE, TNF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.